HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaru Katoh Selected Research

cytochrome P-450 CYP2G1

1/2016Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaru Katoh Research Topics

Disease

83Neoplasms (Cancer)
01/2022 - 01/2002
59Stomach Neoplasms (Stomach Cancer)
02/2020 - 01/2002
40Carcinogenesis
01/2019 - 02/2002
31Pancreatic Neoplasms (Pancreatic Cancer)
02/2020 - 04/2002
29Breast Neoplasms (Breast Cancer)
02/2020 - 01/2002
16Colorectal Neoplasms (Colorectal Cancer)
06/2007 - 02/2002
12Lung Neoplasms (Lung Cancer)
02/2020 - 05/2002
11Neuroblastoma
06/2006 - 10/2003
10Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2013 - 01/2002
10Melanoma (Melanoma, Malignant)
06/2006 - 03/2002
9Prostatic Neoplasms (Prostate Cancer)
09/2017 - 04/2002
9Esophageal Neoplasms (Esophageal Cancer)
12/2006 - 04/2002
9Brain Neoplasms (Brain Tumor)
09/2006 - 08/2004
9Chondrosarcoma
03/2005 - 01/2003
7Colonic Neoplasms (Colon Cancer)
05/2006 - 02/2002
6Neoplasm Metastasis (Metastasis)
02/2010 - 11/2003
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2009 - 10/2002
6Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2004 - 03/2003
5Genetic Translocation (Chromosomal Translocation)
01/2013 - 05/2003
5Carcinoid Tumor (Carcinoid)
04/2006 - 03/2004
5Glioblastoma (Glioblastoma Multiforme)
10/2005 - 02/2002
5Retinoblastoma (Glioblastoma, Retinal)
09/2005 - 06/2003
4Ovarian Neoplasms (Ovarian Cancer)
02/2020 - 03/2003
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2016 - 02/2004
4Infections
06/2013 - 06/2002
4Inflammation (Inflammations)
06/2009 - 07/2003
4Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2007 - 07/2003
4Strabismus (Squint)
07/2002 - 05/2002
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2020 - 04/2003
3Lymphoma (Lymphomas)
02/2020 - 05/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2018 - 08/2016
3Cardiovascular Diseases (Cardiovascular Disease)
12/2016 - 10/2013
3Uterine Neoplasms (Uterine Cancer)
08/2009 - 04/2002
3Oligodendroglioma
11/2005 - 04/2003
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2004 - 03/2002
2Hematologic Neoplasms (Hematological Malignancy)
02/2020 - 02/2003
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2016 - 06/2004
2Triple Negative Breast Neoplasms
03/2014 - 09/2010
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2009 - 07/2005
2Liver Neoplasms (Liver Cancer)
06/2007 - 06/2006
2Atrophic Gastritis
02/2007 - 07/2006
2Squamous Cell Carcinoma of Head and Neck
09/2006 - 08/2003
2Vascular Remodeling
06/2006 - 02/2006
2Rhabdomyosarcoma
02/2006 - 09/2005
2Kidney Neoplasms (Kidney Cancer)
11/2005 - 04/2002
2Leiomyosarcoma
10/2005 - 11/2004

Drug/Important Bio-Agent (IBA)

84Messenger RNA (mRNA)IBA
12/2012 - 01/2002
19Proteins (Proteins, Gene)FDA Link
01/2016 - 05/2002
18Complementary DNA (cDNA)IBA
09/2006 - 04/2002
16beta CateninIBA
09/2005 - 02/2002
9Estradiol (Delestrogen)FDA LinkGeneric
11/2003 - 01/2002
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2009 - 02/2002
6Monoclonal AntibodiesIBA
09/2018 - 12/2005
6Pharmaceutical PreparationsIBA
11/2017 - 08/2003
6Transforming Growth Factor beta (TGF-beta)IBA
02/2010 - 03/2002
5Transcription Factors (Transcription Factor)IBA
02/2020 - 07/2004
5LigandsIBA
08/2016 - 12/2004
5Biomarkers (Surrogate Marker)IBA
01/2016 - 04/2006
4Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
02/2020 - 07/2005
3Phosphotransferases (Kinase)IBA
02/2020 - 04/2006
3DNA (Deoxyribonucleic Acid)IBA
01/2019 - 05/2003
3CateninsIBA
11/2017 - 02/2017
3Estrogen ReceptorsIBA
03/2014 - 08/2009
3MicroRNAs (MicroRNA)IBA
01/2014 - 03/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2013 - 02/2006
3Cadherins (E-Cadherin)IBA
09/2008 - 10/2005
3Protein Isoforms (Isoforms)IBA
04/2005 - 03/2004
3NectinsIBA
09/2004 - 11/2003
3Glycoproteins (Glycoprotein)IBA
01/2003 - 02/2002
3Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2002 - 01/2002
2ClaudinsIBA
02/2020 - 06/2003
2pembrolizumabIBA
09/2018 - 11/2017
2Immune Checkpoint InhibitorsIBA
11/2017 - 07/2016
2TankyrasesIBA
11/2017 - 09/2017
2ICG 001IBA
11/2017 - 09/2017
2LGK974IBA
11/2017 - 09/2017
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2013 - 07/2006
2Estrogens (Estrogen)FDA Link
06/2013 - 01/2003
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
08/2009 - 03/2009
2cediranib (AZD2171)IBA
08/2009 - 08/2008
2NF-kappa B (NF-kB)IBA
05/2009 - 04/2007
2Small Interfering RNA (siRNA)IBA
03/2009 - 06/2004
2Interleukin-6 (Interleukin 6)IBA
06/2007 - 02/2007
2CytokinesIBA
02/2007 - 01/2002
2Gefitinib (Iressa)FDA Link
06/2006 - 04/2006
2Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2006 - 04/2006
2Trastuzumab (Herceptin)FDA Link
06/2006 - 04/2006
2Cetuximab (Erbitux)FDA Link
06/2006 - 04/2006
2Bevacizumab (Avastin)FDA Link
06/2006 - 04/2006
2AntibodiesIBA
12/2005 - 10/2005
2Retinaldehyde (Retinal)IBA
12/2005 - 11/2003
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
08/2005 - 08/2004
2Cysteine (L-Cysteine)FDA Link
05/2005 - 07/2003
2GTP Phosphohydrolases (GTPases)IBA
11/2004 - 10/2004

Therapy/Procedure

25Therapeutics
01/2022 - 03/2003
7Precision Medicine
02/2020 - 06/2004
5Drug Therapy (Chemotherapy)
09/2018 - 07/2005
3Chemoprevention
02/2016 - 07/2003
3Gastrectomy
12/2005 - 06/2004
3Aftercare (After-Treatment)
12/2002 - 01/2002